Diagnosis of Myocardial Viability by Fluorodeoxyglucose Distribution at the Border Zone of a Low Uptake Region

다국어 초록 (Multilingual Abstract)

Purpose: In cardiac 2-[F-18]fluoro-2-deoxy-D-glucose (FDG)-positron emission tomography (PET) examination,interpretation of myocardial viability in the low uptake region (LUR) has been difficult without additional perfusion imaging. We evaluated distribution patterns of FDG at the border zone of the LUR in the cardiac FDG-PET and established a novel parameter for diagnosing myocardial viability and for discriminating the LUR of normal variants. Materials and Methods: Cardiac FDG-PET was performed in patients with a myocardial ischemic event (n = 22) and in healthy volunteers (n = 22). Whether the myocardium was not a viable myocardium (not-VM) or an ischemic but viable myocardium (isch-VM) was defined by an echocardiogram under a low dose of dobutamine infusion as the gold standard. FDG images were displayed as gray scaled-bull’s eye mappings. FDG-plot profiles for LUR (= true ischemic region in the patients or normal variant region in healthy subjects) were calculated.
Maximal values of FDG change at the LUR border zone (a steepness index; Smax scale/pixel) were compared among not-VM, isch-VM, and normal myocardium. Results: Smax was significantly higher for n-VM compared to those with isch-VM or normal myocardium (ANOVA). A cut-off value of 0.30 in Smax demonstrated 100% sensitivity and 83% specificity for diagnosing n-VM and isch-VM. Smax less than 0.23 discriminated LUR in normal myocardium from the LUR in patients with both n-VM and isch-VM with a 94% sensitivity and a 93% specificity.
Conclusion: Smax of the LUR in cardiac FDG-PET is a simple and useful parameter to diagnose n-VM and isch-VM, as well as to discriminate thr LUR of normal variants.

참고문헌 (Reference)

1 Watanabe N, "Three-dimensional microstructural abnormality of the coronary capillary network after myocardial reperfusion--comparison between ‘reflow’ and ‘no-reflow’" 68 : 868-872, 2004

2 Knuuti MJ, "The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET" 34 : 2068-2075, 1993

3 Inglese E, "Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT" 48 : 1662-1669, 2007

4 Porenta G, "Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images" 33 : 1628-1636, 1992

5 Nekolla SG, "Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography" 25 : 1313-1321, 1998

6 Baer FM, "Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization" 28 : 60-69, 1996

7 Schelbert HR, "PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting" 10 : 557-571, 2003

8 Bacharach SL, "PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation" 10 : 543-556, 2003

9 Bax JJ, "Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols" 24 : 35-41, 1997

10 Gropler RJ, "Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans" 31 : 1749-1756, 1990

11 Matsumoto T, "Microheterogeneity of myocardial blood flow in rabbit hearts during normoxic and hypoxic states" 270 : H435-441, 1996

12 Deussen A, "Local myocardial glucose uptake is proportional to, but not dependent on blood flow" 433 : 488-496, 1997

13 Ince C, "Heterogeneity of the hypoxic state in rat heart is determined at capillary level" 264 : H294-301, 1993

14 Altehoefer C, "Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease" 19 : 334-342, 1992

15 Choi Y, "Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans" 20 : 308-318, 1993

16 Sawada S, "Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium" 29 : 55-61, 1997

17 Baumgartner H, "Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts" 32 : 1701-1708, 1998

18 Bax JJ, "Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: headto-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction" 29 : 721-727, 2002

19 Schelbert HR, "18F-deoxyglucose and the assessment of myocardial viability" 32 : 60-69, 2002